...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer

September AGM presentation.  It's worth another listen, starting at 19:10.  Don discusses this partnering for 3694 and breast cancer, also mentioning that he had expected to announce this on Sept 12.

https://www.zenithepigenetics.com/newsroom/events

 

 

Share
New Message
Please login to post a reply